PDGFRA is the most commonly observed amplification, present in approximately 32% of tumors, and highlights an important focal gain implicated in the RTK–Ras–PI3K–Akt signaling network, active in 69% of DIPG (18, 22, 27, 29). The gene discussed is AKT1; the disease is diffuse intrinsic pontine glioma.